Atrial Fibrillation, Stroke, and Bleeding in Patients Undergoing Aortic Biovalve Implantation "CAREAVR"

Completed

Phase N/A Results N/A

Summary of Purpose

The primary purpose of the FIN-bioAVR registry is to assess the incidence of AF, strokes and major bleeding events in patients undergoing aortic valve replacement. This retrospective multicenter registry will include 850 patients with aortic valve replacement using bioprosthesis.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 May 2017.

1 Jan 2002 8 Dec 2015 1 Dec 2015 1 Dec 2015 1 May 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Conditions See All

Sponsors See All

Trial Design

  • Observation: Cohort
  • Perspective: Retrospective
  • Sampling: Non-Probability Sample

Contacts

Not available